Targeting CD226/DNAX accessory molecule-1 (DNAM-1) in collagen-induced arthritis mouse models

Journal of Inflammation (United Kingdom)

Volumn 12, Issue 1, 2015, Pages

  Elhai, Muriel ^a,b   Chiocchia, Gilles ^c   Marchiol, Carmen ^b   Lager, Franck ^b   Renault, Gilles ^b   Colonna, Marco ^d   Bernhardt, Guenter ^e   Allanore, Yannick ^a,b   Avouac, Jérôme ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT COCHIN   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Autoimmunity; CD226; Collagen induced arthritis; Mouse model; Rheumatoid arthritis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CD226 GENE; COLLAGEN-INDUCED ARTHRITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; DISEASE SEVERITY; DNAM 1 GENE; EROSION; GENE; GENE FUNCTION; GENE TARGETING; GENETIC ASSOCIATION; HISTOPATHOLOGY; IN VIVO STUDY; INFLAMMATORY INFILTRATE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE;

MUS;

EID: 84924078370     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/s12950-015-0056-5     Document Type: Article

References (41)

1. Blom M, Kievit W, Fransen J, Kuper IH, den Broeder AA, De Gendt CMA, et al. The reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent does not influence the effect of a second TNF blocking agent in patients with rheumatoid arthritis. J Rheumatol. 2009;36(10):2171-7.
2. Tak PP, Kalden JR. Advances in rheumatology: new targeted therapeutics. Arthritis Res Ther. 2011;13 Suppl 1:S5.
3. Upchurch KS, Kay J. Evolution of treatment for rheumatoid arthritis. Rheumatol Oxf Engl. 2012;51 Suppl 6:vi28-36.
4. Boissier MC. Cell and cytokine imbalances in rheumatoid synovitis. Jt Bone Spine Rev Rhum. 2011;78(3):230-4.
5. Fournier C. Where do T cells stand in rheumatoid arthritis? Jt Bone Spine Rev Rhum. 2005;72(6):527-32.
6. Dieudé P. Rheumatic diseases: environment and genetics. Jt Bone Spine Rev Rhum. 2009;76(6):602-7.
7. Bax M, van Heemst J, Huizinga TWJ, Toes REM. Genetics of rheumatoid arthritis: what have we learned? Immunogenetics. 2011;63(8):459-66.
8. Deshmukh H, Kim-Howard X, Nath SK. Replication of recently identified associated single-nucleotide polymorphisms from six autoimmune diseases in Genetic Analysis Workshop 16 rheumatoid arthritis data. BMC Proc. 2009;3 Suppl 7:S31.
9. Lettre G, Rioux JD. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet. 2008;17(R2):R116-21.
10. Anaya J-M. The autoimmune tautology. Arthritis Res Ther. 2010;12(6):147.
11. Hafler JP, Maier LM, Cooper JD, Plagnol V, Hinks A, Simmonds MJ, et al. CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun. 2009;10(1):5-10.
12. Dieudé P, Guedj M, Truchetet ME, Wipff J, Revillod L, Riemekasten G, et al. Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis. Arthritis Rheum. 2011;63(4):1097-105.
13. Maiti AK, Kim-Howard X, Viswanathan P, Guillén L, Qian X, Rojas-Villarraga A, et al. Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases. Rheumatol Oxf Engl. 2010;49(7):1239-44.
14. Qiu Z-X, Zhang K, Qiu X-S, Zhou M, Li W-M. CD226 Gly307Ser association with multiple autoimmune diseases: A meta-analysis. Hum Immunol. 2013;74(2):249-55.
15. Du Y, Shen L-X, Yu L-K, Song Y, Zhu J-F, Du R. The CD226 gene in susceptibility of rheumatoid arthritis in the Chinese Han population. Rheumatol Int. 2012;32(5):1299-304.
16. Liu R, Xu N, Wang X, Shen L, Zhao G, Zhang H, et al. Influence of MIF, CD40, and CD226 polymorphisms on risk of rheumatoid arthritis. Mol Biol Rep. 2012;39(6):6915-22.
17. Deshmukh HA, Maiti AK, Kim-Howard XR, Rojas-Villarraga A, Guthridge JM, Anaya J-M, et al. Evaluation of 19 autoimmune disease-associated loci with rheumatoid arthritis in a Colombian population: evidence for replication and gene-gene interaction. J Rheumatol. 2011;38(9):1866-70.
18. Suzuki T, Ikari K, Kawaguchi Y, Yano K, Iwamoto T, Kawamoto M, et al. Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility in Japanese rheumatoid arthritis patients. Mod Rheumatol Jpn Rheum Assoc. 2013;23(1):200-2.
19. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T, et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity. 1996;4(6):573-81.
20. Boissier M-C, Semerano L, Challal S, Saidenberg-Kermanac'h N, Falgarone G. Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction. J Autoimmun. 2012;39(3):222-8.
21. Fasth AER, Björkström NK, Anthoni M, Malmberg K-J, Malmström V. Activating NK-cell receptors co-stimulate CD4(+)CD28(-) T cells in patients with rheumatoid arthritis. Eur J Immunol. 2010;40(2):378-87.
22. Myers LK, Rosloniec EF, Cremer MA, Kang AH. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 1997;61(19):1861-78.
23. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 1980;283(5748):666-8.
24. Durie FH, Fava RA, Noelle RJ. Collagen-induced arthritis as a model of rheumatoid arthritis. Clin Immunol Immunopathol. 1994;73(1):11-8.
25. Gilfillan S, Chan CJ, Cella M, Haynes NM, Rapaport AS, Boles KS, et al. DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. J Exp Med. 2008;205(13):2965-73.
26. Guéry L, Batteux F, Bessis N, Breban M, Boissier MC, Fournier C, et al. Expression of Fas ligand improves the effect of IL-4 in collagen-induced arthritis. Eur J Immunol. 2000;30(1):308-15.
27. Inglis JJ, Criado G, Medghalchi M, Andrews M, Sandison A, Feldmann M, et al. Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen. Arthritis Res Ther. 2007;9(5):R113.
28. Campbell IK, Hamilton JA, Wicks IP. Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol. 2000;30(6):1568-75.
29. Avouac J, Elhai M, Tomcik M, Ruiz B, Friese M, Piedavent M, et al. Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis. Ann Rheum Dis. 2013;72(6):1089-98.
30. Tahara-Hanaoka S, Shibuya K, Kai H, Miyamoto A, Morikawa Y, Ohkochi N, et al. Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor. Blood. 2006;107(4):1491-6.
31. Yamashita Y, Abe F, Hirochika R, Tahara-Hanaoka S, Shibuya A, Shibuya K. Establishment and characterization of a novel anti-DNAM-1 monoclonal antibody. Monoclon Antib Immunodiagn Immunother. 2013;32(1):60-4. doi: 10.1089/mab.2012.0083.
32. Glatigny S, Blaton M-A, Mencher SK, Mistou S, Lucas B, Fournier C, et al. Treatment of collagen-induced arthritis by Natura-alpha via regulation of Th-1/Th-17 responses. Eur J Immunol. 2010;40(2):460-9.
33. Elhai M, Jérôme A, Marchiol C, Renault G, Ruiz B, Fréchet M, et al. Performance of skin ultrasound to measure skin involvement in different animal models of systemic sclerosis. Ultrasound Med Biol. 2013;39(5):845-52.
34. Clavel G, Marchiol-Fournigault C, Renault G, Boissier M-C, Fradelizi D, Bessis N. Ultrasound and Doppler micro-imaging in a model of rheumatoid arthritis in mice. Ann Rheum Dis. 2008;67(12):1765-72.
35. Saidenberg-Kermanac'h N, Bessis N, Lemeiter D, de Vernejoul M-C, Boissier M-C, Cohen-Solal M. Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis. J Clin Immunol. 2004;24(4):370-8.
36. Song G, Bae S-C, Choi S, Ji J, Lee Y. Association between the CD226 rs763361 polymorphism and susceptibility to autoimmune diseases: A meta-analysis. Lupus. 2012;21(14):1522-30.
37. Gan EH, Mitchell AL, Macarthur K, Pearce SHS. The role of a nonsynonymous CD226 (DNAX-accessory molecule-1) variant (Gly 307Ser) in isolated Addison's disease and autoimmune polyendocrinopathy type 2 pathogenesis. Clin Endocrinol (Oxf). 2011;75(2):165-8.
38. Nabekura T, Shibuya K, Takenaka E, Kai H, Shibata K, Yamashita Y, et al. Critical role of DNAX accessory molecule-1 (DNAM-1) in the development of acute graft-versus-host disease in mice. Proc Natl Acad Sci U S A. 2010;107(43):18593-8.
39. Anaya J-M, Gómez L, Castiblanco J. Is there a common genetic basis for autoimmune diseases? Clin Dev Immunol. 2006;13(2-4):185-95.
40. Dardalhon V, Schubart AS, Reddy J, Meyers JH, Monney L, Sabatos CA, et al. CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions. J Immunol Baltim Md 1950. 2005;175(3):1558-65.
41. Kai H, Shibuya K, Wang Y, Kameta H, Kameyama T, Tahara-Hanaoka S, et al. Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice. Immunology. 2006;118(2):233-9.